ResultsIQ › Latest results › Nephrocare Health Services Limited
Nephrocare Health Services Limited Q3 FY26 earnings call summary
NSE: NEPHROPLUS · BSE: 544647
Earnings call of 11 Feb 2026, summarised by AI from the filing.
NephroPlus Q3 FY26 revenue ₹260 cr (+32% YoY) with adjusted PAT ₹34 cr; guides 15%-20% revenue CAGR over 3-4 years.
Key takeaways
- Guidance Management guides 15%-20% revenue CAGR over 3-4 years; no annual guidance given.
- International mix International revenue rose to 41% of total in 9M FY26 from 12% in FY23.
- Growth drivers Growth from existing clinic ramp-up, roll-ups in existing countries, and new country or large PPP acquisitions.
- Execution risk Quarter-level visibility limited; execution can spill over from one quarter to the next.
Nephrocare Health Services Limited Q1 FY27 results
As filed: Revenue ₹282 cr, EBITDA ₹63.9 cr, PAT ₹32.0 cr, EBITDA margin 22.7%.
Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹282 cr). Scored once a year-earlier consolidated quarter exists.
Earlier results and the share price after them
- Q4 FY26: Revenue ₹266 cr, EBITDA ₹53.8 cr, PAT ₹30.4 cr, EBITDA margin 20.2%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹266 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +11.3% in 30 days (Nifty 500: +3.0%).
- Q3 FY26: Revenue ₹260 cr, EBITDA ₹60.9 cr, PAT ₹32.2 cr, EBITDA margin 23.4%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹260 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +4.5% in 30 days (Nifty 500: −7.8%).
Past price moves after results do not indicate future moves. Not a recommendation.
Nephrocare Health Services Limited earnings call, investor presentation and press release summaries
- Q1 FY27: Earnings call (12 Aug 2026), Results deck (11 Aug 2026), Results press release (11 Aug 2026)
- Q4 FY26: Earnings call (20 May 2026), Results deck (19 May 2026), Results press release (19 May 2026)
- Q3 FY26: Earnings call (11 Feb 2026), Results deck (10 Feb 2026), Results press release (10 Feb 2026)
Figures from the company's filings with NSE and BSE. Not investment advice.